Latest Articles

Publication Date
High Response Rates in Platinum-Resistant Ovarian Cancer With Immunotherapy Agents - MedPage Today

High Response Rates in Platinum-Resistant Ovarian Cancer With Immunotherapy Agents MedPage Today

Published: April 16, 2026, 7:11 p.m.
Epigenetic Compound Library Screen Identifies Ibrutinib as an Inhibitor of Ovarian Clear Cell Carcinoma Viability.

Ovarian clear cell carcinoma (OCCC) is an endometriosis-associated ovarian cancer subtype. Somatic mutations in OCCC are reported in ARID1A, PIK3CA, and the TERT promoter (TERTp), as well as less commonly …

Published: April 10, 2026, midnight
Endometriosis and Endometrial Cancer-Association Between Biological Mechanisms and Its Clinical Implications.

Endometriosis and endometrial cancer are distinct gynecological conditions that share overlapping biological mechanisms with implications for clinical management. Endometriosis is a chronic, benign disorder characterized by the ectopic implantation of …

Published: April 10, 2026, midnight
CAR-NKT cell therapy offers scalable, off-the-shelf immunotherapy for endometrial carcinoma - Oncology Central

CAR-NKT cell therapy offers scalable, off-the-shelf immunotherapy for endometrial carcinoma Oncology Central

Published: March 23, 2026, 9:45 a.m.
CAR-NKT cell therapy: a scalable immunotherapy option for endometrial carcinoma - Oncology Central

CAR-NKT cell therapy: a scalable immunotherapy option for endometrial carcinoma Oncology Central

Published: March 23, 2026, 9:45 a.m.
CAR-NKT Immunotherapy Eliminates Endometrial Tumors in Preclinical Models - Cure Today

CAR-NKT Immunotherapy Eliminates Endometrial Tumors in Preclinical Models Cure Today

Published: March 17, 2026, 5:11 p.m.
CAR-NKT Immunotherapy Eliminates Endometrial Tumors in Preclinical Models - CUREtoday.com

CAR-NKT Immunotherapy Eliminates Endometrial Tumors in Preclinical Models CUREtoday.com

Published: March 17, 2026, 4:12 p.m.
CAR-NKT Immunotherapy Shows Preclinical Success Against Endometrial Tumors - Technology Networks

CAR-NKT Immunotherapy Shows Preclinical Success Against Endometrial Tumors Technology Networks

Published: March 17, 2026, 4:04 p.m.
UCLA Researchers Say Universal, Ready-To-Use Immunotherapy Detects and Destroys Endometrial Cancer - Sierra Sun Times

UCLA Researchers Say Universal, Ready-To-Use Immunotherapy Detects and Destroys Endometrial Cancer Sierra Sun Times

Published: March 17, 2026, 2:29 p.m.
Universal, ready-to-use immunotherapy detects and destroys endometrial cancer in preclinical tests - Medical Xpress

Universal, ready-to-use immunotherapy detects and destroys endometrial cancer in preclinical tests Medical Xpress

Published: March 16, 2026, 10:20 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!